Cardiac involvement in sickle β-thalassemia

Annals of Hematology

Volumn 88, Issue 6, 2009, Pages 557-564

  Aessopos, Athanasios ^a,b   Farmakis, Dimitrios ^a   Trompoukis, Christos ^a   Tsironi, Maria ^a   Moyssakis, Ioannis ^a   Tsaftarides, Panagiotis ^a   Karagiorga, Markisia ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b LAIKO GENERAL HOSPITAL   (Greece)

Author keywords

Heart failure; Pulmonary hypertension; Sickle cell disease; Sickle thalassemia; Thalassemia

Indexed keywords

IRON;

ADULT; ARTICLE; BIVENTRICULAR DILATATION; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; FEMALE; HEART CATHETERIZATION; HEART DILATATION; HEART FUNCTION; HEART INDEX; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE MASS; HEART SIZE; HUMAN; LUNG ARTERY PRESSURE; LUNG WEDGE PRESSURE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; SICKLE CELL BETA THALASSEMIA; SYSTOLIC BLOOD PRESSURE; ADOLESCENT; AGED; BETA THALASSEMIA; ELECTROCARDIOGRAPHY; HEART DISEASE; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY;

ADOLESCENT; ADULT; AGED; BETA-THALASSEMIA; ELECTROCARDIOGRAPHY; FEMALE; HEART DISEASES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED;

EID: 67651050076     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-008-0661-y     Document Type: Article

References (44)

1. Lane P (1996) Sickle cell disease. Ped Clin N Am 43:639-664. doi: 10.1016/S0031-3955(05)70426-0
2. Loukopoulos D (1996) Current status of thalassemia and the sickle cell syndromes in Greece. Semin Hematol 33:76-86
3. Tsironi M, Aessopos A (2005) The heart in sickle cell disease. Acta Cardiol 60:589-598. doi: 10.2143/AC.60.6.2004929
4. Aessopos A, Farmakis D, Deftereos S, Tsironi M, Tassiopoulos S, Moyssakis I et al (2005) Thalassemia heart disease: A comparative evaluation of thalassemia major and thalassemia intermedia. Chest 127:1523-1530. doi: 10.1378/chest.127.5.1523
5. Moyssakis I, Tzanetea R, Tsaftaridis P, Rombos I, Papadopoulos DP, Kalotychou V et al (2005) Systolic and diastolic function in middle aged patients with sickle beta thalassaemia. An echocardiographic study. Postgrad Med J 81:711-714. doi: 10.1136/pgmj.2004.031096
6. Aessopos A, Tsironi M, Vassiliadis I, Farmakis D, Fountos A, Voskaridou E et al (2001) Exercise-induced myocardial perfusion abnormalities in sickle beta-thalassemia: Tc-99m tetrofosmin gated SPECT imaging study. Am J Med 111:355-360. doi: 10.1016/S0002-9343(01)00835-X
7. Aessopos A, Farmakis D, Tsironi M, Diamanti-Kandarakis E, Matzourani M, Fragodimiri C et al (2006) Endothelial function and arterial stiffness in sickle-thalassemia patients. Atherosclerosis 191:427-432. doi: 10.1016/j.atherosclerosis.2006.04.015
8. Aessopos A, Farmakis D, Hatziliami A, Fragodimitri C, Karabatsos F, Joussef J et al (2004) Cardiac status in well-treated patients with thalassemia major. Eur J Haematol 73:359-366. doi: 10.1111/ j.1600-0609.2004.00304.x
9. Sahn DJ, De Maria A, Kisslo J, Weyman A (1978) The committee on M-mode standardization of the American Society of Echocardiography: Results of a survey of echocardiographic measurements. Circulation 58:1072-1083
10. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H et al (1989) Recommendations for quantitation of the left ventricle by two-dimensional echocardiography: American Society of Echocardiography Committee on Standards Subcommittee. J Am Soc Echocardiogr 2:358-367
11. Feigenbaum H (1994) Echocardiographic evaluation of cardiac chambers. In: Feigenbaum H (ed) Echocardiography. 5th edn. Lea & Febiger, Philadelphia, pp 134-173
12. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I et al (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57:450-458. doi: 10.1016/ 0002-9149(86)90771-X
13. Lubien E, DeMaria A, Krishnaswamy P, Clopton P, Koon J, Kazanegra R et al (2002) Utility of B-natriuretic peptide in detecting diastolic dysfunction: Comparison with Doppler velocity recordings. Circulation 105:595-601. doi: 10.1161/hc0502.103010
14. Chan KL, Currie PJ, Seward JB, Hagler DJ, Mair DD, Tajik AJ (1987) Comparison of three Doppler ultrasound methods in the prediction of pulmonary artery disease. J Am Coll Cardiol 9:549-554
15. Aessopos A, Farmakis D, Taktikou H, Loukopoulos D (2000) Doppler-determined peak systolic tricuspid pressure gradient in persons with normal pulmonary function and tricuspid regurgitation. J Am Soc Echocardiogr 13:645-649. doi: 10.1067/mje.2000.104535
16. Feigenbaum H, Armstrong W (2004) Feigenbaum's echocardiography, 6th edn. Lippincott Williams & Wilkins, Philadelphia
17. Raman SV, Simonetti OP, Cataland SR, Kraut EH (2006) Myocardial ischemia and right ventricular dysfunction in adult patients with sickle cell disease. Haematologica 91:1329-1335
18. Voskaridou E, Douskou M, Terpos E, Papassotiriou I, Stamoulakatou A, Ourailidis A et al (2004) Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease. Br J Haematol 126:736-742. doi: 10.1111/j.1365-2141.2004.05104.x
19. Sachdev V, Machado RF, Shizukuda Y, Rao YN, Sidenko S, Ernst I et al (2007) Diastolic dysfunction is an independent risk factor for death in patients with sickle cell disease. J Am Coll Cardiol 49:472-479. doi: 10.1016/j.jacc.2006.09.038
20. Murray JF, Dawson AM, Sherlock S (1958) Circulatory changes in chronic liver diseases. Am J Med 24:358-367. doi: 10.1016/0002-9343(58)90322-X
21. Aessopos A, Farmakis D, Loukopoulos D (2002) Elastic tissue abnormalities resembling pseudoxanthoma elasticum in beta thalassemia and the sickling syndromes. Blood 99:30-35. doi: 10.1182/blood.V99.1.30
22. Aessopos A, Farmakis D, Loukopoulos D (2002) Elastic tissue abnormalities in inherited haemolytic syndromes. Eur J Clin Invest 32:640-642. doi: 10.1046/j.1365-2362.2002.01033.x
23. Aessopos A, Farmakis D (2004) Sickle cell disease: Introducing a distinct elastic tissue defect associated with inherited hemolytic syndromes. In: Plasmar RL (ed) Focus on sickle cell research. Nova Biomedical Books, New York, pp 157-179
24. Aessopos A, Voskaridou E, Kavouklis E, Vassilopoulos G, Rombos Y, Gavriel L et al (1994) Angioid streaks in sickle-thalassemia. Am J Ophthalmol 117:589-592
25. Tsomi K, Karagiorga-Lagana M, Karabatsos F, Fragodimitri C, van Vliet-Konstantinidou C, Premetis E et al (2001) Arterial elastorrhexis in beta-thalassaemia intermedia, sickle cell thalassaemia and hereditary spherocytosis. Eur J Haematol 67:135-141. doi: 10.1034/ j.1600-0609.2001.5790349.x
26. Aessopos A, Deftereos S, Farmakis D, Corovesis C, Tassiopoulos S, Tsironi M et al (2004) Cardiovascular adaptation to chronic anemia in the elderly: An echocardiographic study. Clin Invest Med 27:265-273
27. Cheung YF, Chan GC, Ha SY (2002) Arterial stiffness and endothelial function in patients with beta-thalassemia major. Circulation 106:2561-2566. doi: 10.1161/01.CIR.0000037225.92759.A7
28. Kato GJ, Martyr S, Blackwelder WC, Nichols JS, Coles WA, Hunter LA et al (2005) Levels of soluble endothelium-derived adhesion molecules in patients with sickle cell disease are associated with pulmonary hypertension, organ dysfunction, and mortality. Br J Haematol 130:943-953. doi: 10.1111/j.1365-2141.2005.05701.x
29. Wood JC, Tyszka JM, Carson S, Nelson MD, Coates TD (2004) Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease. Blood 103:1934-1936. doi: 10.1182/blood-2003-06-1919
30. Tsironi M, Polonifi K, Deftereos S, Farmakis D, Andriopoulos P, Moyssakis I et al (2005) Transfusional hemosiderosis and combined chelation therapy in sickle thalassemia. Eur J Haematol 75:355-358. doi: 10.1111/j.1600-0609.2005.00528.x
31. Aessopos A, Samarcos M, Hadjinikolaou P, Vaiopoulos G, Skoumas V, Kolainis I et al (1996) Myocardial infarction with normal coronary arteries in S/beta thalassaemia patients. Eur Heart J 17:317-318
32. Rubler S, Fleischer RA (1967) Sickle cell states and cardiomyopathy. Sudden death due to pulmonary thrombosis and infarction. Am J Cardiol 19:867-873. doi: 10.1016/0002-9149(67)90510-3
33. Lippman SM, Abergel RP, Ginzton LE, Uitto J, Tanaka KR, Miyamoto EK et al (1985) Mitral valve prolapse in sickle cell disease: Manifestation of a generalized connective tissue disorder. Am J Hematol 19:1-12. doi: 10.1002/ajh.2830190102
34. Gladwin MT, Sachdev V, Jison ML, Shizukuda Y, Plehn JF, Minter K et al (2004) Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med 350:886-895. doi: 10.1056/ NEJMoa035477
35. Voskaridou E, Tsetsos G, Tsoutsias A, Spyropoulou E, Christoulas D, Terpos E (2007) Pulmonary hypertension in patients with sickle cell/beta thalassemia: Incidence and correlation with serum N-terminal pro-brain natriuretic peptide concentrations. Haematologica 92:738-743. doi: 10.3324/haematol.11136
36. Ataga KI, Sood N, De Gent G, Kelly E, Henderson AG, Jones S et al (2004) Pulmonary hypertension in sickle cell disease. Am J Med 117:665-669. doi: 10.1016/j.amjmed.2004.03.034
37. Derchi G, Forni GL, Formisano F, Cappellini MD, Galanello R, D'Ascola G et al (2005) Efficacy and safety of sildenafil in the treatment of severe pulmonary hypertension in patients with hemoglobinopathies. Haematologica 90:452-458
38. Hsu LL, Champion HC, Campbell-Lee SA, Bivalacqua TJ, Manci EA, Diwan BA et al (2007) Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability. Blood 109:3088-3098. doi: 10.1182/blood-2006-06-029173
39. Morris CR, Kato GJ, Poljakovic M, Wang X, Blackwelder WC, Sachdev V et al (2005) Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. JAMA 294:81-90. doi: 10.1001/jama.294.1.81
40. Kato GJ, McGowan V, Machado RF, Little JA, Taylor J 6th, Morris CR, Nichols JS, Wang X, Poljakovic M, Morris SM Jr, Gladwin MT (2006) Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood 107:2279-2285. doi: 10.1182/blood-2005-06-2373
41. Machado RF, Kyle Mack A, Martyr S, Barnett C, Macarthur P, Sachdev V et al (2007) Severity of pulmonary hypertension during vaso-occlusive pain crisis and exercise in patients with sickle cell disease. Br J Haematol 136:319-325. doi: 10.1111/j.1365-2141.2006.06417.x
42. Steinberg MH, Rosenstock W, Coleman MB, Adams JG, Platica O, Cedeno M et al (1984) Effects of thalassemia and microcytosis on the hematologic and vaso-occlusive severity of sickle cell anemia. Blood 63:1353-1360
43. Aessopos A, Farmakis D, Karagiorga M, Voskaridou E, Loutradi A, Hatziliami A et al (2001) Cardiac involvement in thalassemia intermedia: a multicenter study. Blood 97:3411-3416. doi: 10.1182/blood.V97.11.3411
44. Kato GJ, Onyekwere OC, Gladwin MT (2007) Pulmonary hypertension in sickle cell disease: Relevance to children. Pediatr Hematol Oncol 24:159-170. doi: 10.1080/08880010601185892